8th Microbiome Movement Drug Development Summit

  • June 28, 2023 - June 30, 2023
  • Boston, MA, USA

Biomica’s CEO, Dr. Elran Haber, will participate in a panel at the upcoming 8th Microbiome Movement Drug Development Summit, titled: “Evaluating Current Market Dynamics to Navigate Future Investment Possibilities”.

For more details and registration: https://microbiome-summit.com/

Back to all News

Highlighted News About Biomica

May 23, 2024

Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma

Preliminary Phase 1 results show promising trends for BMC128 in combination with nivolumab in refractory cancer patients. Data will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting REHOVOT, Israel, May 23, 2024. Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: […]